ACLS

Fair Value

Price (monthly) Typical-P/S value line (dashed = revenue estimates) above fair value below fair value
Overvalued
+280%
vs fair value
Price
$127
Fair value
$33.45
Today's P/S
4.5x
Typical P/S, 20y
1.2x
Revenue/share growth rate
4.1%
Trailing 12M revenue/share
$28.06

Results are highly cyclical for ACLS, so multiple-based fair value is less reliable here.

FY2005200620072009201120122013201420152016201720182019202020212022202320242025E2026E2027E2028E
High9.358.0026.526.5214.687.529.9610.2413.6414.5536.6331.3024.8931.2674.5686.52200155
Low4.124.785.920.684.323.124.366.169.368.9614.1515.5414.0613.4228.6047.9578.2069.18
Rev/Sh14.8418.2615.845.2512.017.567.177.2710.519.1413.1313.6710.5614.1819.7527.8734.5031.2726.55E28.76E32.18E40.56E
Chg/Yr+23%-13%-67%+129%-37%-5%+1%+44%-13%+44%+4%-23%+34%+39%+41%+24%-9%-15%+8%+12%+26%
Div0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
How these numbers are calculated

Fair value (1.2x sales) multiplies each year's revenue per share by the price-to-sales ratio investors have typically paid for ACLS — the median of the last 20 fiscal years' average price over that year's revenue per share. The line extends forward with analyst revenue estimates (dashed).

Today's P/S (4.5x) is the current price over the last twelve months of revenue per share. Compare it to the typical ratio to see whether today's pricing is rich or cheap on sales.

Revenue comes from reported quarters; share counts come from market value divided by the share price, so buybacks and splits are handled correctly. The verdict calls a stock over- or undervalued only when the price sits more than 10% from the line.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.